COL22A1 and neoplasm: We found many inserts in genes scored with moderate confidence (score 3 out of 4) as oncogenes—COL22A1, CSMD3, GaBRG2, PGM5, RALYL, RGS22, RSRC1, and TRPS1—while no inserts were in candidate tumour suppressors at confidence 3 or 4.